Copyright Reports & Markets. All rights reserved.

Global Human Liver Models Market Report 2018-2029

Request for Sample of this report
Buy now

1 Industry Overview of Human Liver Models

  • 1.1 Research Scope
  • 1.2 Market Segmentation by Types of Human Liver Models
  • 1.3 Market Segmentation by End Users of Human Liver Models
  • 1.4 Market Dynamics Analysis of Human Liver Models
    • 1.4.1 Market Drivers
    • 1.4.2 Market Challenges
    • 1.4.3 Market Opportunities
    • 1.4.4 Porter’s Five Forces

2 Major Manufacturers Analysis of Human Liver Models Industry

  • 2.1 Emulate
    • 2.1.1 Company Overview
    • 2.1.2 Main Products and Specifications
    • 2.1.3 Human Liver Models Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.1.4 Contact Information
  • 2.2 Ascendance Bio
    • 2.2.1 Company Overview
    • 2.2.2 Main Products and Specifications
    • 2.2.3 Human Liver Models Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.2.4 Contact Information
  • 2.3 InSphero
    • 2.3.1 Company Overview
    • 2.3.2 Main Products and Specifications
    • 2.3.3 Human Liver Models Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.3.4 Contact Information
  • 2.4 CN Bio
    • 2.4.1 Company Overview
    • 2.4.2 Main Products and Specifications
    • 2.4.3 Human Liver Models Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.4.4 Contact Information
  • 2.5 Organovo
    • 2.5.1 Company Overview
    • 2.5.2 Main Products and Specifications
    • 2.5.3 Human Liver Models Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.5.4 Contact Information
  • 2.6 Cyfuse Biomedical
    • 2.6.1 Company Overview
    • 2.6.2 Main Products and Specifications
    • 2.6.3 Human Liver Models Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.6.4 Contact Information
  • 2.7 Mimetas
    • 2.7.1 Company Overview
    • 2.7.2 Main Products and Specifications
    • 2.7.3 Human Liver Models Sales Volume, Revenue, Price and Gross Margin (2018-2023)
    • 2.7.4 Contact Information

3 Global Human Liver Models Market Analysis by Regions, Manufacturers, Types and End Users

  • 3.1 Global Sales Volume and Revenue of Human Liver Models by Regions (2018-2023)
  • 3.2 Global Sales Volume and Revenue of Human Liver Models by Manufacturers (2018-2023)
  • 3.3 Global Sales Volume and Revenue of Human Liver Models by Types (2018-2023)
  • 3.4 Global Sales Volume and Revenue of Human Liver Models by End Users (2018-2023)
  • 3.5 Selling Price Analysis of Human Liver Models by Regions, Manufacturers, Types and End Users in (2018-2023)

4 Northern America Human Liver Models Market Analysis by Countries, Types and End Users

  • 4.1 Northern America Human Liver Models Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 4.2 Northern America Human Liver Models Sales Volume and Revenue Analysis by Types (2018-2023)
  • 4.3 Northern America Human Liver Models Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 4.4 United States Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 4.5 Canada Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)

5 Europe Human Liver Models Market Analysis by Countries, Types and End Users

  • 5.1 Europe Human Liver Models Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 5.2 Europe Human Liver Models Sales Volume and Revenue Analysis by Types (2018-2023)
  • 5.3 Europe Human Liver Models Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 5.4 Germany Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.5 France Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.6 UK Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.7 Italy Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.8 Russia Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.9 Spain Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 5.10 Netherlands Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)

6 Asia Pacific Human Liver Models Market Analysis by Countries, Types and End Users

  • 6.1 Asia Pacific Human Liver Models Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 6.2 Asia Pacific Human Liver Models Sales Volume and Revenue Analysis by Types (2018-2023)
  • 6.3 Asia Pacific Human Liver Models Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 6.4 China Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.5 Japan Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.6 Korea Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.7 India Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.8 Australia Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.9 Indonesia Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 6.10 Vietnam Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)

7 Latin America Human Liver Models Market Analysis by Countries, Types and End Users

  • 7.1 Latin America Human Liver Models Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 7.2 Latin America Human Liver Models Sales Volume and Revenue Analysis by Types (2018-2023)
  • 7.3 Latin America Human Liver Models Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 7.4 Brazil Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 7.5 Mexico Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 7.6 Argentina Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 7.7 Colombia Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)

8 Middle East & Africa Human Liver Models Market Analysis by Countries, Types and End Users

  • 8.1 Middle East & Africa Human Liver Models Sales Volume and Revenue Analysis by Countries (2018-2023)
  • 8.2 Middle East & Africa Human Liver Models Sales Volume and Revenue Analysis by Types (2018-2023)
  • 8.3 Middle East & Africa Human Liver Models Sales Volume and Revenue Analysis by End Users (2018-2023)
  • 8.4 Turkey Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 8.5 Saudi Arabia Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 8.6 South Africa Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)
  • 8.7 Egypt Human Liver Models Sales Volume, Revenue, Import and Export Analysis (2018-2023)

9 Marketing Channel, Distributors and Traders Analysis

  • 9.1 Marketing Channel
    • 9.1.1 Direct Channel
    • 9.1.2 Indirect Channel
  • 9.2 Distributors and Traders

10 Global Human Liver Models Market Forecast by Regions, Countries, Manufacturers, Types and End Users

  • 10.1 Global Sales Volume and Revenue Forecast of Human Liver Models by Regions (2024-2029)
  • 10.2 Global Sales Volume and Revenue Forecast of Human Liver Models by Types (2024-2029)
  • 10.3 Global Sales Volume and Revenue Forecast of Human Liver Models by End Users (2024-2029)
  • 10.4 Global Revenue Forecast of Human Liver Models by Countries (2024-2029)
    • 10.4.1 United States Revenue Forecast (2024-2029)
    • 10.4.2 Canada Revenue Forecast (2024-2029)
    • 10.4.3 Germany Revenue Forecast (2024-2029)
    • 10.4.4 France Revenue Forecast (2024-2029)
    • 10.4.5 UK Revenue Forecast (2024-2029)
    • 10.4.6 Italy Revenue Forecast (2024-2029)
    • 10.4.7 Russia Revenue Forecast (2024-2029)
    • 10.4.8 Spain Revenue Forecast (2024-2029)
    • 10.4.9 Netherlands Revenue Forecast (2024-2029)
    • 10.4.10 China Revenue Forecast (2024-2029)
    • 10.4.11 Japan Revenue Forecast (2024-2029)
    • 10.4.12 Korea Revenue Forecast (2024-2029)
    • 10.4.13 India Revenue Forecast (2024-2029)
    • 10.4.14 Australia Revenue Forecast (2024-2029)
    • 10.4.15 Indonesia Revenue Forecast (2024-2029)
    • 10.4.16 Vietnam Revenue Forecast (2024-2029)
    • 10.4.17 Brazil Revenue Forecast (2024-2029)
    • 10.4.18 Mexico Revenue Forecast (2024-2029)
    • 10.4.19 Argentina Revenue Forecast (2024-2029)
    • 10.4.20 Colombia Revenue Forecast (2024-2029)
    • 10.4.21 Turkey Revenue Forecast (2024-2029)
    • 10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
    • 10.4.23 South Africa Revenue Forecast (2024-2029)
    • 10.4.24 Egypt Revenue Forecast (2024-2029)

11 Industry Chain Analysis of Human Liver Models

  • 11.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Human Liver Models
    • 11.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Human Liver Models
    • 11.1.2 Major Equipment Suppliers with Contact Information Analysis of Human Liver Models
  • 11.2 Downstream Major Consumers Analysis of Human Liver Models
  • 11.3 Major Suppliers of Human Liver Models with Contact Information
  • 11.4 Supply Chain Relationship Analysis of Human Liver Models

12 Human Liver Models New Project Investment Feasibility Analysis

  • 12.1 Human Liver Models New Project SWOT Analysis
  • 12.2 Human Liver Models New Project Investment Feasibility Analysis
    • 12.2.1 Project Name
    • 12.2.2 Investment Budget
    • 12.2.3 Project Product Solutions
    • 12.2.4 Project Schedule

13 Human Liver Models Research Findings and Conclusion

    14 Appendix

    • 14.1 Research Methodology
    • 14.2 References and Data Sources
      • 14.2.1 Primary Sources
      • 14.2.2 Secondary Paid Sources
      • 14.2.3 Secondary Public Sources
    • 14.3 Abbreviations and Units of Measurement
    • 14.4 Author Details

    Human liver models are in vitro models that simulate the structure, function, and physiology of the human liver. These models are used for drug discovery, toxicity testing, disease modeling, and educational purposes. The use of human liver models enables researchers to study the mechanisms of liver diseases, test the efficacy and safety of new drugs, and reduce the need for animal testing.

    The global human liver models market size in 2022 is estimated to reach US$226.9 million, with a compound annual growth rate of 9.7%. This growth can be attributed to various factors such as increasing demand for advanced and efficient drug discovery methods, increasing funding for liver research, and advancements in technology related to liver models.

    Human liver models are mainly used for drug discovery, education, and other purposes. The drug discovery segment dominates the market, accounting for more than 60% of the total revenue. Human liver models enable researchers to perform drug screening and toxicity testing in a more accurate and efficient manner, reducing the costs and time associated with traditional in vivo and in vitro methods.

    The major global manufacturers in the human liver models industry include Emulate, Ascendance Bio, InSphero, CN Bio, Organovo, Cyfuse Biomedical, and Mimetas. These companies focus on developing innovative products, expanding their geographic presence, and enhancing the efficiency and reliability of their liver models.

    North America dominates the human liver models market, followed by Europe and the Asia-Pacific region. This can be attributed to the high prevalence rates of liver diseases, strong healthcare infrastructure, and advanced medical technologies in these regions. However, emerging markets such as China and India present significant opportunities for growth due to increasing healthcare infrastructure and a growing demand for advanced medical technologies.

    In conclusion, human liver models are essential tools for drug discovery, toxicity testing, and disease modeling. The market's growth is driven by factors such as increasing demand for efficient drug discovery methods, funding for liver research, and advancements in technology related to liver models. The major global manufacturers in the industry are investing in research and development to create innovative products and expand their market share. With continued adoption in both established and emerging markets, the human liver models industry presents potential opportunities for growth in the future.

    The SWOT analysis of the Human Liver Models industry is as follows:

    Strengths:
    Human liver models provide an innovative and efficient solution for drug discovery and toxicity testing, reducing costs and time associated with traditional in vivo and in vitro methods.
    The increasing prevalence of liver diseases globally and the growing demand for advanced medical technologies present significant opportunities for growth in the industry.
    Advancements in technology related to human liver models, such as the use of microfluidics and 3D printing, enable researchers to create more accurate and reliable models, improving patient outcomes.

    Weaknesses:
    The high cost associated with the development and use of human liver models may limit their use in certain regions or smaller healthcare organizations.
    The potential safety concerns related to the accuracy and efficacy of human liver models can create market barriers and reduce patient confidence.
    Stringent regulatory requirements and approval processes for medical devices can create obstacles for new product launches and approvals.

    Opportunities:
    Increasing focus on personalized healthcare and precision diagnostics can lead to the development of new and innovative liver models tailored to specific patient needs.
    Growing demand for advanced medical technologies in emerging markets such as China, India, and Brazil represents major growth opportunities for the industry.
    Partnerships and collaborations with healthcare providers and government agencies can increase market penetration and improve product adoption rates.

    Threats:
    Competition from established global manufacturers could impact smaller players looking to enter the market.
    New technological developments or alternative treatments may reduce the demand for liver models.
    Economic instability and changes in healthcare policies can affect sales and revenue growth.

    Key players in global Human Liver Models market include:
    Emulate
    Ascendance Bio
    InSphero
    CN Bio
    Organovo
    Cyfuse Biomedical
    Mimetas

    Market segmentation, by product types:
    Liver Organoids
    Liver-on-a-chip
    2D Models
    3D Bioprinting
    Others

    Market segmentation, by applications:
    Drug Discovery
    Education
    Others
    Buy now